Snapshot of our 2020 Investors & Pharma BD


The LSX Nordic Congress investors represent some of the most reputable firms across European life sciences - check them out below.

VIEW INVESTOR PREFERENCE REPORT

Adara Ventures

Alpha Blue Ocean Advisors

Almi Invest

ALSA Ventures

aMoon

Apogee

AX Capital

Axilium Capital

Bayer

Bedrock

Beiersdorf

bio4dreams 300x

Bonit Capital

Bonnier

BVV

Butterfly

Caixa Capital

Capital Family Office 300x150

Capricorn Partners

Claris Ventures

Cleveland Clinic

debere capital

Debiopharm Group

DiaMedCare

Digitalis

DNB

Dynamk Capital

Earlybird Venture Capital

EIR Partners

Emerging Longevity Ventures

Fosun Private Equity 300x150

F-Prime Capital 300x150

GEM

Graybella Capital

Hadean Ventures

HCR Partners

Helsinn Investment Fund 300x150

hermes partners

HKSTP

Human Alfa

Ignite Capital Partners

Illumina-Ventures

IMEC

Industrifonden

INKEF Capital

Innovestor Ventures

Jeito Resize

Jolt Capital

JT Ventures

Karolina Ventures

Kissei America 300x150

Kreos Capital

Kurma Partners

Limerston Capital

Longliv ventures

Luminous Ventures

Lundbeckfonden Update

Medcity 300x

Melior Capital Management

M Ventures

NEA

NCL Technology Ventures 300x150

New Science Fund

Nextech 300x

Nina Capital

Nordvest

Northpond Ventures

Novo Holdings

Optum Ventures

Peppermint Venture Partners

Playfair Capital

Pluscap

R Ventures

RMI Partners

Roche

RYSE Asset Management

Sanara Ventures

Schibsted

Serendipity Partners

Seroba Life Sciences

SHS Capital

SpeedUp Venture Capital Group

Startcodon

Startup Health

Stoaf 300x

Sunstone Life Science Ventures

Swedbank Robur

TCPAM

Telia 300x

TenX Health

Tesi

Triventures 300x

Triwise Capital

Trumpf Ventures

Tuspark

TVM Capital

UCB Pharma

Unicorn Capital Partner

Ventac Partners

VI Partners

Voima Ventures

Vickers Venture Partners

Wellington Partners